Thermosensitive Injectable Sacran‐Based Hydrogel with Superbroad Hydrophobic Domains for Rigid Drug‐Controlled Release in Full‐Thickness Skin Wound Therapy
Macromolecular Bioscience · 2026
DOI: 10.1002/mabi.202500658 ↗Kurz gefasst
Fachartikel in der Zeitschrift Macromolecular Bioscience, 2026. Verfasst von Chengqun Yu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Synthetic and Biological Colloids, School of Chemical and Material Engineering, Jiangnan University, Wuxi, Jiangsu, P. R. China. Hauptthemen laut MEDLINE: Hydrogels, Wound Healing, Polysaccharides, Skin. Die Arbeit nennt 43 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities, the Research Fund for International Scientists (RFIS) by the National Natural Science Foundation of China (NSFC).
Abstract (Originalsprache)
Persistent bacterial infections and prolonged inflammation often complicate full‐thickness skin wound healing, underscoring the limitations of current dressings and the overuse of antibiotics. Herein, we developed a novel injectable hydrogel for full‐thickness wound repair. The hydrogel matrix is composed of sacran, a supergiant polysaccharide with broad hydrophobic domains and abundant hydroxyl groups. Thermosensitivity was conferred upon the matrix through the incorporation of poly(ethylene glycol)‐block‐poly(propylene glycol)‐block‐poly(ethylene glycol). Two rigid bioactive molecules, tannic acid (TA) and dipotassium glycyrrhizinate (DG), were co‐loaded within the hydrogel. Their sustained release was achieved by the strong hydrophobic interactions inherent to sacran, which were further stabilized by hydrogen bonding. The synergistic drugs effectively modulate the wound microenvironment by exerting ∼100% antibacterial efficacy against both Gram‐positive and Gram‐negative bacteria, significant reactive oxygen species (ROS) scavenging (>94%2,2‐diphenyl‐1‐picrylhydrazyl (DPPH) scavenging), suppression of pro‐inflammatory cytokines (interleukin‐6 (IL‐6), tumor necrosis factor‐α (TNF‐α)), and pro‐angiogenic motion of angiogenesis and collagen deposition. In vivo studies confirmed accelerated wound closure, complete re‐epithelialization, robust neovascularization, and appendage regeneration, significantly surpassing commercial Tegaderm performance. This multifunctional sacran‐based injectable hydrogel emerges as a highly promising biomaterial, establishing a synergistic therapeutic strategy for complex skin injuries and advanced wound care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Synthetic and Biological Colloids, School of Chemical and Material Engineering, Jiangnan University, Wuxi, Jiangsu, P. R. China.
- School of Life Science, School of Interdisciplinary Science, Key Laboratory of Molecular Medicine and Biotherapy, Key Laboratory of Medical Molecule Science and Pharmaceutics Engineering, Aerospace Center Hospital, Beij…
ORCID-Profile: Tatsuo Kaneko
Förderung
- Fundamental Research Funds for the Central Universities
- the Research Fund for International Scientists (RFIS) by the National Natural Science Foundation of China (NSFC)
Zitieren
APA
Yu, C., Naeem, A., Ali, M. A., Okajima, M. K., & Kaneko, T. (2026). Thermosensitive Injectable Sacran‐Based Hydrogel with Superbroad Hydrophobic Domains for Rigid Drug‐Controlled Release in Full‐Thickness Skin Wound Therapy. Macromolecular Bioscience. https://doi.org/10.1002/mabi.202500658
Vancouver
Yu C, Naeem A, Ali MA, Okajima MK, Kaneko T. Thermosensitive Injectable Sacran‐Based Hydrogel with Superbroad Hydrophobic Domains for Rigid Drug‐Controlled Release in Full‐Thickness Skin Wound Therapy. Macromolecular Bioscience. 2026. doi:10.1002/mabi.202500658
BibTeX
@article{Yu2026,
author = {Yu, Chengqun and Naeem, Abid and Ali, Mohammad Asif and Okajima, Maiko Kaneko and Kaneko, Tatsuo},
title = {Thermosensitive Injectable Sacran‐Based Hydrogel with Superbroad Hydrophobic Domains for Rigid Drug‐Controlled Release in Full‐Thickness Skin Wound Therapy},
journal = {Macromolecular Bioscience},
year = {2026},
doi = {10.1002/mabi.202500658}
}
EUVIMED